<code id='DD2F027A55'></code><style id='DD2F027A55'></style>
    • <acronym id='DD2F027A55'></acronym>
      <center id='DD2F027A55'><center id='DD2F027A55'><tfoot id='DD2F027A55'></tfoot></center><abbr id='DD2F027A55'><dir id='DD2F027A55'><tfoot id='DD2F027A55'></tfoot><noframes id='DD2F027A55'>

    • <optgroup id='DD2F027A55'><strike id='DD2F027A55'><sup id='DD2F027A55'></sup></strike><code id='DD2F027A55'></code></optgroup>
        1. <b id='DD2F027A55'><label id='DD2F027A55'><select id='DD2F027A55'><dt id='DD2F027A55'><span id='DD2F027A55'></span></dt></select></label></b><u id='DD2F027A55'></u>
          <i id='DD2F027A55'><strike id='DD2F027A55'><tt id='DD2F027A55'><pre id='DD2F027A55'></pre></tt></strike></i>

          knowledge

          knowledge

          author:Wikipedia    Page View:57
          John-Arne-Røttingen, a white man with short hair, smiles at the camera wearing blue suits — biotech coverage from STAT
          John-Arne Røttingen is the head of the Wellcome Trust, one of the world’s top private funders of biomedical research. Illustration: STAT; Source: Wellcome Trust

          LONDON — The key groups involved in addressing global health problems often include governments, foundations, and pharmaceutical companies.

          But to John-Arne Røttingen, the new head of the Wellcome Trust, one of the world’s top private funders of biomedical research, there’s another sector that should be getting involved — the tech industry.

          advertisement

          The Alphabets and Amazons of the world have been growing their health-related initiatives, but the industry is rarely mentioned when neglected public health issues are discussed, Røttingen argued.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          New requirements coming in 2024 for Americans traveling to Europe
          New requirements coming in 2024 for Americans traveling to Europe

          4:04ThecoverofaU.S.PassportisdisplayedinTigard,Ore.,Dec.11,2021.JennyKane/AP,FILEAnyonelookingtotrav

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          'The Earth is screaming at us': Gov. Inslee calls for climate action amid record heat

          5:50InthisApril22,2022,filephoto,WashingtonstateGovernorJayInsleespeakspriortoPresidentJoeBidenatGre